Circulating tumor DNA: A potential biomarker from solid tumors' monitor to anticancer therapies

Circulating tumor DNA: A potential biomarker from solid tumors' monitor to anticancer therapies

Circulating tumor DNA (ctDNA) in the peripheral blood is a liquid biopsy that contains representative tumor information including gene mutations. ctDNA is a promising new avenue for real-time monitoring of tumor progression. As a noninvasive biomarker and potential surrogate for the entire tumor gen...

Full description

Bibliographic Details
Main Authors: Ting Chen, Rongzhang He, Xinglin Hu, Weihao Luo, Zheng Hu, Jia Li, Lili Duan, Yali Xie, Wenna Luo, Tan Tan, Di-Xian Luo
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Cancer Translational Medicine
Subjects:
Circulating tumor DNA
liquid biopsy
precise therapy
tumor
Online Access:http://www.cancertm.com/article.asp?issn=2395-3977;year=2017;volume=3;issue=2;spage=64;epage=67;aulast=Chen

Internet

http://www.cancertm.com/article.asp?issn=2395-3977;year=2017;volume=3;issue=2;spage=64;epage=67;aulast=Chen

Similar Items